From yoghurt to gene editing
Food-industry scientists studying how to protect yoghurt cultures from viruses helped show, in the 2000s, that CRISPR is a bacterial immune system.
MHI 095 · Exhibition
2012
Documented dateBerkeley, California, United States, and Umeå, Sweden
Plate 095
2012
Berkeley, California, United States, and Umeå, Sweden
Jennifer Doudna and Emmanuelle Charpentier and colleagues published the CRISPR-Cas9 programmable system in Science in June 2012. A first CRISPR-based therapy, for sickle cell disease, was approved in the UK and US in 2023.
There has been a long patent dispute between teams at Berkeley and the Broad Institute.
The world before
Editing genes was slow, expensive and unreliable.
The human achievement
The researchers showed that a guide RNA could direct the Cas9 enzyme to a specific DNA sequence and cut it. In 2018, He Jiankui announced the birth of gene-edited babies, which was condemned worldwide and he was imprisoned.
Understanding the invention
CRISPR Gene Editing, explained in two steps.
Step 01 of 02
RNA tells the Cas9 enzyme where to cut.
IV
The transformation
Treatments for sickle cell disease and beta thalassemia.
Labs worldwide use it.
CRISPR made editing genes faster and cheaper, with potential for treating genetic disease, improving crops and understanding biology, along with serious ethical questions.
Before and after
Before
Years of work.
After
Weeks.
On larger screens, drag the divider (or use the arrow keys) to give more room to the world before or after.
VI
Its legacy
MHI 095
CRISPR Gene Editing
Beyond the collection
mRNA vaccines
Part of a broader biotechnology revolution.
Beyond the collection
Ethics
Debate over editing human embryos.
Human stories
Food-industry scientists studying how to protect yoghurt cultures from viruses helped show, in the 2000s, that CRISPR is a bacterial immune system.
Where accounts differ, this museum follows the documented record and says so.
Next in the museum
Related exhibitions